Skip to main content
Clinical Trials/IRCT20180923041103N1
IRCT20180923041103N1
Completed
Phase 2

Evaluating the effects of combination therapy with Erythropoietin and Methylprednisolone in patients with traumatic cervical spinal cord injury

Mashhad University of Medical Sciences0 sites54 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Traumatic Cervical Spinal Cord Injury.
Sponsor
Mashhad University of Medical Sciences
Enrollment
54
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patient with Acute Traumatic Cervical Spinal Cord Injury
  • Admitted within 8 hours of injury
  • Neurological lesion at C5 to C7 level
  • Stable hemodynamics

Exclusion Criteria

  • Vascular Brain Disease
  • Acute Myocardial Infarction
  • Thrombotic Diseases
  • Cardiac Arrhythmia
  • Heart Failure
  • Peripheral Vascular Disorders
  • Polycythemia
  • Neurological Disorders
  • Known Psychiatric Disorders
  • Acute or Chronic Kidney Disease

Outcomes

Primary Outcomes

Not specified

Similar Trials